Cargando…

Apelin: A potential novel serum biomarker for early detection of diabetic nephropathy in patients with type 2 diabetes

OBJECTIVE: Diabetic nephropathy (DN) is the major cause of chronic renal failure, and proteinuria is an independent risk factor for the end stage renal disease. The random urine protein: creatinine ratio (P:C ratio) can accurately predict the amount of 24-hour urinary protein excretion. Apelin is th...

Descripción completa

Detalles Bibliográficos
Autores principales: Demirpence, Mustafa, Yilmaz, Hamiyet, Colak, Ayfer, Pamuk, Baris Onder, Karakoyun, Inanc, Basok, Banu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593907/
https://www.ncbi.nlm.nih.gov/pubmed/31297482
http://dx.doi.org/10.14744/nci.2018.62134
_version_ 1783430148100456448
author Demirpence, Mustafa
Yilmaz, Hamiyet
Colak, Ayfer
Pamuk, Baris Onder
Karakoyun, Inanc
Basok, Banu
author_facet Demirpence, Mustafa
Yilmaz, Hamiyet
Colak, Ayfer
Pamuk, Baris Onder
Karakoyun, Inanc
Basok, Banu
author_sort Demirpence, Mustafa
collection PubMed
description OBJECTIVE: Diabetic nephropathy (DN) is the major cause of chronic renal failure, and proteinuria is an independent risk factor for the end stage renal disease. The random urine protein: creatinine ratio (P:C ratio) can accurately predict the amount of 24-hour urinary protein excretion. Apelin is thought to be associated with endothelial dysfunction, angiogenesis, and inflammation. This study investigated the apelin concentration and its association with the urine P:C ratio, and metabolic parameters in subjects with and without type 2 diabetes mellitus (T2D). METHODS: This study involved 86 subjects: 56 with newly diagnosed and untreated T2D and 30 non-diabetic controls. All subjects underwent a complete clinical examination that included anthropometric and laboratory measurements. RESULTS: Twenty-four males and sixty-two females participated in this study, and their mean age was 52.27±11.34 years. There were no differences in age, thyrotropin-stimulating hormone (TSH), creatinine clearance, and apelin levels between groups. As expected, fasting plasma glucose, weight, body mass index, and HbA1C were higher in T2D subjects (p=0.001, p=0.02, p=0.03, and p=0.001, respectively). Although apelin levels were higher in the control group, the differences were not statistically significant (p=0.93). The P:C ratio levels were lower in the control group, and the differences were statistically significant (p=0.006). A Spearman correlation analysis revealed that serum apelin levels were not correlated with the urine P:C ratio. CONCLUSION: Our study demonstrates that T2D is associated with decreased serum apelin levels and increased urine P:C ratios compared to those in non-diabetic subjects. This association may depend on impaired glucose homeostasis. Our results show that the serum apelin levels were not correlated with the urine protein: creatinine ratio and provide further evidence regarding the relationship between apelin and DN.
format Online
Article
Text
id pubmed-6593907
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Kare Publishing
record_format MEDLINE/PubMed
spelling pubmed-65939072019-07-11 Apelin: A potential novel serum biomarker for early detection of diabetic nephropathy in patients with type 2 diabetes Demirpence, Mustafa Yilmaz, Hamiyet Colak, Ayfer Pamuk, Baris Onder Karakoyun, Inanc Basok, Banu North Clin Istanb Original Article OBJECTIVE: Diabetic nephropathy (DN) is the major cause of chronic renal failure, and proteinuria is an independent risk factor for the end stage renal disease. The random urine protein: creatinine ratio (P:C ratio) can accurately predict the amount of 24-hour urinary protein excretion. Apelin is thought to be associated with endothelial dysfunction, angiogenesis, and inflammation. This study investigated the apelin concentration and its association with the urine P:C ratio, and metabolic parameters in subjects with and without type 2 diabetes mellitus (T2D). METHODS: This study involved 86 subjects: 56 with newly diagnosed and untreated T2D and 30 non-diabetic controls. All subjects underwent a complete clinical examination that included anthropometric and laboratory measurements. RESULTS: Twenty-four males and sixty-two females participated in this study, and their mean age was 52.27±11.34 years. There were no differences in age, thyrotropin-stimulating hormone (TSH), creatinine clearance, and apelin levels between groups. As expected, fasting plasma glucose, weight, body mass index, and HbA1C were higher in T2D subjects (p=0.001, p=0.02, p=0.03, and p=0.001, respectively). Although apelin levels were higher in the control group, the differences were not statistically significant (p=0.93). The P:C ratio levels were lower in the control group, and the differences were statistically significant (p=0.006). A Spearman correlation analysis revealed that serum apelin levels were not correlated with the urine P:C ratio. CONCLUSION: Our study demonstrates that T2D is associated with decreased serum apelin levels and increased urine P:C ratios compared to those in non-diabetic subjects. This association may depend on impaired glucose homeostasis. Our results show that the serum apelin levels were not correlated with the urine protein: creatinine ratio and provide further evidence regarding the relationship between apelin and DN. Kare Publishing 2018-08-14 /pmc/articles/PMC6593907/ /pubmed/31297482 http://dx.doi.org/10.14744/nci.2018.62134 Text en Copyright: © 2019 by Istanbul Northern Anatolian Association of Public Hospitals http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Original Article
Demirpence, Mustafa
Yilmaz, Hamiyet
Colak, Ayfer
Pamuk, Baris Onder
Karakoyun, Inanc
Basok, Banu
Apelin: A potential novel serum biomarker for early detection of diabetic nephropathy in patients with type 2 diabetes
title Apelin: A potential novel serum biomarker for early detection of diabetic nephropathy in patients with type 2 diabetes
title_full Apelin: A potential novel serum biomarker for early detection of diabetic nephropathy in patients with type 2 diabetes
title_fullStr Apelin: A potential novel serum biomarker for early detection of diabetic nephropathy in patients with type 2 diabetes
title_full_unstemmed Apelin: A potential novel serum biomarker for early detection of diabetic nephropathy in patients with type 2 diabetes
title_short Apelin: A potential novel serum biomarker for early detection of diabetic nephropathy in patients with type 2 diabetes
title_sort apelin: a potential novel serum biomarker for early detection of diabetic nephropathy in patients with type 2 diabetes
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593907/
https://www.ncbi.nlm.nih.gov/pubmed/31297482
http://dx.doi.org/10.14744/nci.2018.62134
work_keys_str_mv AT demirpencemustafa apelinapotentialnovelserumbiomarkerforearlydetectionofdiabeticnephropathyinpatientswithtype2diabetes
AT yilmazhamiyet apelinapotentialnovelserumbiomarkerforearlydetectionofdiabeticnephropathyinpatientswithtype2diabetes
AT colakayfer apelinapotentialnovelserumbiomarkerforearlydetectionofdiabeticnephropathyinpatientswithtype2diabetes
AT pamukbarisonder apelinapotentialnovelserumbiomarkerforearlydetectionofdiabeticnephropathyinpatientswithtype2diabetes
AT karakoyuninanc apelinapotentialnovelserumbiomarkerforearlydetectionofdiabeticnephropathyinpatientswithtype2diabetes
AT basokbanu apelinapotentialnovelserumbiomarkerforearlydetectionofdiabeticnephropathyinpatientswithtype2diabetes